These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 30721724

  • 1. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY, Shah DA, Dave RH.
    Int J Pharm; 2019 Mar 25; 559():348-359. PubMed ID: 30721724
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Design of Experiments-Driven Optimization of Spray Drying for Amorphous Clotrimazole Nanosuspension.
    Gajera B, Shah H, Parekh B, Rathod V, Tilala M, Dave RH.
    AAPS PharmSciTech; 2024 Jul 13; 25(6):164. PubMed ID: 38997569
    [Abstract] [Full Text] [Related]

  • 5. Investigating a Novel Hot Melt Extrusion-Based Drying Technique to Solidify an Amorphous Nanosuspension Using Design of Experiment Methodology.
    Gajera BY, Shah DA, Dave RH.
    AAPS PharmSciTech; 2018 Nov 13; 19(8):3778-3790. PubMed ID: 30280356
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk assessment and QbD based optimization of an Eprosartan mesylate nanosuspension: In-vitro characterization, PAMPA and in-vivo assessment.
    Shekhawat P, Pokharkar V.
    Int J Pharm; 2019 Aug 15; 567():118415. PubMed ID: 31175989
    [Abstract] [Full Text] [Related]

  • 8. Fabrication of Ibrutinib Nanosuspension by Quality by Design  Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability.
    Rangaraj N, Pailla SR, Chowta P, Sampathi S.
    AAPS PharmSciTech; 2019 Oct 28; 20(8):326. PubMed ID: 31659558
    [Abstract] [Full Text] [Related]

  • 9. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
    Karakucuk A, Celebi N, Teksin ZS.
    Eur J Pharm Sci; 2016 Dec 01; 95():111-121. PubMed ID: 27181836
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S, Reddy VA, Arora S, Patel K.
    Drug Deliv Transl Res; 2016 Oct 01; 6(5):498-510. PubMed ID: 27129488
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Design of selegiline-loaded bio-nanosuspension for the management of depression using novel bio-retardant from Manilkara zapota.
    Tyagi Y, Madhav NVS.
    Drug Dev Ind Pharm; 2019 Aug 01; 45(8):1351-1360. PubMed ID: 31084445
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
    Rao Q, Qiu Z, Huang D, Lu T, Zhang ZJ, Luo D, Pan P, Zhang L, Liu Y, Guan S, Li Q.
    Eur J Pharm Sci; 2019 Feb 01; 128():222-231. PubMed ID: 30553058
    [Abstract] [Full Text] [Related]

  • 20. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y, Li N, Zhao X, Li Y, Ge Y, Wang W, Wang K, Liu Y.
    Int J Pharm; 2014 Apr 10; 464(1-2):1-9. PubMed ID: 24456674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.